Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Clinical and immunological response to photodynamic therapy in the treatment of vulval intraepithelial neoplasia.

Daayana S, Winters U, Stern PL, Kitchener HC.

Photochem Photobiol Sci. 2011 May;10(5):802-9. doi: 10.1039/c0pp00344a. Epub 2011 Apr 14. Review.

PMID:
21494722
2.

Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.

Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN.

Cancer Res. 2001 Jan 1;61(1):192-6.

3.

Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy.

Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C.

Gynecol Oncol. 2006 Feb;100(2):271-5. Epub 2005 Sep 16.

PMID:
16169064
4.
5.

Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.

Campbell SM, Gould DJ, Salter L, Clifford T, Curnow A.

Br J Dermatol. 2004 Nov;151(5):1076-80.

PMID:
15541088
6.

Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid.

Fehr MK, Hornung R, Schwarz VA, Simeon R, Haller U, Wyss P.

Gynecol Oncol. 2001 Jan;80(1):62-6.

PMID:
11136571
7.

Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid.

Hillemanns P, Untch M, Dannecker C, Baumgartner R, Stepp H, Diebold J, Weingandt H, Pröve F, Korell M.

Int J Cancer. 2000 Mar 1;85(5):649-53.

8.

Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid.

Fehr MK, Hornung R, Degen A, Schwarz VA, Fink D, Haller U, Wyss P.

Lasers Surg Med. 2002;30(4):273-9.

PMID:
11948597
9.
10.

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

Davidson EJ, Boswell CM, Sehr P, Pawlita M, Tomlinson AE, McVey RJ, Dobson J, Roberts JS, Hickling J, Kitchener HC, Stern PL.

Cancer Res. 2003 Sep 15;63(18):6032-41.

11.

Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination.

Skapa P, Zamecnik J, Hamsikova E, Salakova M, Smahelova J, Jandova K, Robova H, Rob L, Tachezy R.

Am J Surg Pathol. 2007 Dec;31(12):1834-43.

PMID:
18043037
12.

[Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].

Hadzić B, Djurdjević S, Hadzić M, Jerant-Patić V.

Med Pregl. 1998 May-Jun;51(5-6):265-70. Croatian.

PMID:
9720356
13.

Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid.

Zawislak A, Donnelly RF, McCluggage WG, Price JH, McClelland HR, Woolfson AD, Dobbs S, Maxwell P, McCarron PA.

Photodiagnosis Photodyn Ther. 2009 Mar;6(1):28-40. doi: 10.1016/j.pdpdt.2009.03.004. Epub 2009 May 5.

PMID:
19447369
14.

Human papillomavirus infections and vulvar disease development.

Garland SM, Insinga RP, Sings HL, Haupt RM, Joura EA.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1777-84. doi: 10.1158/1055-9965.EPI-09-0067.

15.

Rapid spontaneous regression of acute-onset vulvar intraepithelial neoplasia 3 in young women: a case series.

Stephenson RD, Denehy TR.

J Low Genit Tract Dis. 2012 Jan;16(1):56-8. doi: 10.1097/LGT.0b013e31822d93ee.

PMID:
22207153
16.

The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).

Srodon M, Stoler MH, Baber GB, Kurman RJ.

Am J Surg Pathol. 2006 Dec;30(12):1513-8.

PMID:
17122506
17.

[Photodynamic therapy in vulvar intraepithelial neoplasia].

Olejek A, Kozak-Darmas I, Biniszkiewicz T, Kellas-Sleczka S, Sieroń A.

Ginekol Pol. 2008 Apr;79(4):276-80. Polish.

PMID:
18592866
18.

The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.

van de Nieuwenhof HP, van Kempen LC, de Hullu JA, Bekkers RL, Bulten J, Melchers WJ, Massuger LF.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2061-7. doi: 10.1158/1055-9965.EPI-09-0209. Epub 2009 Jun 30.

19.

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC.

Clin Cancer Res. 2003 Nov 1;9(14):5205-13.

20.

Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.

Rufforny I, Wilkinson EJ, Liu C, Zhu H, Buteral M, Massoll NA.

J Low Genit Tract Dis. 2005 Apr;9(2):108-13.

PMID:
15870532

Supplemental Content

Support Center